Corcept Therapeutics
Clinical trials sponsored by Corcept Therapeutics, explained in plain language.
-
New drug trial targets root cause of dangerous hormone surge
Disease control CompletedThis study tested whether a drug called relacorilant could safely treat high cortisol levels caused by benign adrenal tumors. It involved 137 patients who also had high blood pressure or diabetes. Participants were randomly assigned to receive either the real drug or a placebo fo…
Phase: PHASE3 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for Tough-to-Treat ovarian cancer?
Disease control CompletedThis study tested whether adding a new oral drug called relacorilant to standard chemotherapy (nab-paclitaxel) could better control cancer growth in women with recurrent ovarian, fallopian tube, or primary peritoneal cancer that had stopped responding to platinum-based drugs. It …
Phase: PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Hidden hormone link to stubborn high blood pressure investigated in major U.S. study
Knowledge-focused CompletedThis study aimed to find out how common a hidden hormone problem (called endogenous hypercortisolism) is in people whose high blood pressure does not respond well to multiple medications. Over 1,100 adults with this 'resistant hypertension' across the U.S. were enrolled. Research…
Sponsor: Corcept Therapeutics • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC